Tuberculosis in Hong Kong - Patient characteristics and treatment outcome

Hong Kong Medical Journal

Volumn 9, Issue 2, 2003, Pages 83-90

  Tam, C M ^a   Leung, C C ^a   Noertjojo, K ^b   Chan, S L ^c   Chan Yeung, M ^b  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Hong Kong UST   (Hong Kong)

Author keywords

Demography; Disease management; Treatment outcome; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; COMORBIDITY; FEMALE; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RETREATMENT; RETROSPECTIVE STUDY; SCREENING; SILICOSIS; SPUTUM SMEAR; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIABETES MELLITUS; FEMALE; HONG KONG; HUMANS; INFANT; INFANT, NEWBORN; LIVER DISEASES; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; REGISTRIES; RETROSPECTIVE STUDIES; SEX FACTORS; SILICOSIS; TREATMENT OUTCOME; TREATMENT REFUSAL; TUBERCULOSIS, PULMONARY;

EID: 0037386152     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hong Kong Government Tuberculosis and Chest Service. Annual Report 1971-2001.
2. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994;72:213-20.
3. Tuberculosis control and research strategies for the 1990s: memorandum from a WHO meeting. Bull World Health Organ 1992;70:17-21.
4. Hong Kong Government Tuberculosis and Chest Service. Annual Report 1970.
5. Hong Kong Advisory Council on AIDS. HIV/AIDS situation in Hong Kong. Report August 2000 to July 2001,4-5.
6. Leung CC, Tam CM. Guidance notes for notification of tuberculosis. Public Health Epidemiol Bull 1999;8:36-9.
7. International Union Against Tuberculosis and Lung Disease. Management of tuberculosis. A guide for low income countries. 5th ed. Paris: International Union Against Tuberculosis and Lung Disease; 2000:36-9.
8. Census and Statistics Department, Hong Kong. 1996 population bycensus.
9. Census and Statistics Department, Hong Kong. Annual Digest of Statistics; 2002.
10. Chan-Yeung M, Noertjojo K, Chan SL, Tam CM. Sex differences in tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2002;6:11-8.
11. Janus ED. The Hong Kong cardiovascular risk factors 1995-1996. Hong Kong: Hospital Authority; 1997:48.
12. Meijer J, Barnett GD, Kubik A, Styblo, K. Identification of sources of infection [in French]. Bull Int Union Tuberc 1971;45:5-54.
13. Toman K. Mass radiography in tuberculosis control. WHO Chron 1976;30:51-7.
14. Survey of patients presenting to the government chest service in Hong Kong and the effects of active tuberculosis case-finding by publicity campaigns. Hong Kong Chest Service/British Medical Research Council. Tubercle 1984;65:173-84.
15. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49:1-51.
16. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-8.
17. Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001. MMWR Morb Mortal Wkly Rep 2001;50:733-5.
18. Noertjojo K, Tam CM, Chan SL, Tan J, Chan-Yeung M. Contact examination for tuberculosis in Hong Kong is useful. Int J Tuberc Lung Dis 2002;6:19-24.
19. Woo J, Chan HS, Hazlett CB, et al. Tuberculosis among elderly Chinese in residential homes: tuberculin reactivity and estimated prevalence. Gerontology 1996;42:155-62.
20. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health. JAMA 1998;279:943-8.
21. Sukrakanchana-Trikham P, Puechal X, Rigal J, Rieder H. 10-year assessment of treatment outcome among Cambodian refugees with sputum smear-positive tuberculosis in Khao-I-Dang, Thailand. Tuber Lung Dis 1992;73:384-7.
22. Westaway MS, Conradie PW, Remmers L. Supervised out-patient treatment of tuberculosis: evaluation of a South African rural programme. Tubercle 1991;72:140-4.
23. Wilkinson D. High compliance tuberculosis treatment programme in a rural community. Lancet 1994;343:647-8.
24. Manalo F, Tan F, Sbarbaro JA, Iseman MD. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance. Am Rev Respir Dis 1990;142:1301-5.
25. Miles SH, Maat RB. A successful supervised outpatient short-course tuberculosis treatment program in an open refugee camp on the Thai-Cambodia border. Am Rev Respir Dis 1984;130:827-30.
26. Schluger N, Ciotoli C, Cohen D, Johnson H, Rom WN. Comprehensive tuberculosis control for patients at high risk for noncompliance. Am J Respir Crit Care Med 1995:151:1486-90.
27. Kan GO, Zhang LX, Wu JC, Ma ZI, Liu CW, Sun FZ. Supervised intermittent chemotherapy for pulmonary tuberculosis in a rural area of China. Tubercle 1985;66:1-7.
28. el-Sadr W, Medard F, Berthaud V, Barthaud V. Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993. Am J Public Health 1996:86:1146-9.
29. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995;274:945-51.
30. Werhane MJ, Snukst-Torbeck G, Schraufnagel DE. The tuberculosis clinic. Chest 1989;96:815-8.
31. Chan SL, Wong PC, Tam CM. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong. Tuber Lung Dis 1994;75:245-50.
32. Pozsik CJ. Compliance with tuberculosis therapy. Med Clin North Am 1993;77:1289-301.
33. Cowie RL, Brink BA. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet. S Afr Med J 1990;77:390-1.
34. Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med 1990;112:407-15.
35. Caminero JA, Pavon JM, Rodriguez de Castro F, et al. Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance. Thorax 1996;51:1130-3.
36. Study of a fully supervised programme of chemotherapy for pulmonary tuberculosis given once weekly in the continuation phase in the rural areas of Hong Kong. Tubercle 1984;65:5-15.
37. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber Lung Dis 1993;74:32-7.
38. Wolde K, Lema E, Roscigno G, Abdi A. Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis. Ethiop Med J 1992;30:63-8.
39. Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Int J Tuberc Lung Dis 2001;5:815-23.